Evidence for the Role of Peroxisome Proliferator-Activated Receptor-β/δ in the Development of Spinal Cord Injury

被引:42
|
作者
Paterniti, Irene [1 ]
Esposito, Emanuela [1 ,3 ]
Mazzon, Emanuela [1 ]
Galuppo, Maria [1 ]
Di Paola, Rosanna [3 ]
Bramanti, Placido [3 ]
Kapoor, Amar [2 ]
Thiemermann, Christoph [2 ]
Cuzzocrea, Salvatore [3 ]
机构
[1] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Torre Biol Policlin Univ, I-98100 Messina, Italy
[2] St Bartholomews & Royal London Sch Med & Dent, Ctr Expt Med Nephrol & Crit Care, William Harvey Res Inst, London, England
[3] Ctr Neurolesi Bonino Pulejo, Inst Ricovero & Cura Carattere Sci, Messina, Italy
关键词
CYTOKINE PRODUCTION; IN-VIVO; MECHANISMS; APOPTOSIS; LIPOPOLYSACCHARIDE; DIFFERENTIATION; INFLAMMATION; EXPRESSION; LIGANDS; ATHEROSCLEROSIS;
D O I
10.1124/jpet.110.165605
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several lines of evidence suggest a biological role for peroxisome proliferator-activated receptor (PPAR)-beta/delta in the pathogenesis many diseases. The aim of the present study was to evaluate the contribution of PPAR-beta/delta in the secondary damage in experimental spinal cord injury (SCI) in mice. To this purpose, we used 4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methylphenoxy]acetic acid (GW0742), a high-affinity PPAR-beta/delta agonist. Spinal cord trauma was induced by the application of vascular clips (force of 24 g) to the dura via a four-level T-5 to T-8 laminectomy. SCI in mice resulted in severe trauma characterized by edema, neutrophil infiltration, production of inflammatory mediators, tissue damage, and apoptosis. GW0742 treatment (0.3 mg kg(-1) i.p.) 1 and 6 h after the SCI significantly reduced 1) the degree of spinal cord inflammation and tissue injury (histological score), 2) neutrophil infiltration (myeloperoxidase activity), 3) nitrotyrosine formation, 4) proinflammatory cytokines expression, 5) nuclear factor-kappa B activation, 6) inducible nitric-oxide synthase expression, and 6) apoptosis (terminal deoxynucleotidyl transferase dUTP nick-end labeling staining, FasL, Bax, and Bcl-2 expression). Moreover, GW0742 significantly ameliorated the recovery of limb function (evaluated by motor recovery score). To elucidate whether the protective effects of GW0742 are related to activation of the PPAR-beta/delta receptor, we also investigated the effect of PPAR-beta/delta antagonist methyl-3-({[2-(methoxy)-4-phenyl]amino}sulfonyl)-2-thiophenecarboxylate (GSK0660) on the protective effects of GW0742. GSK0660 (1 mg/kg i.p. 30 min before treatment with GW0742) significantly blocked the effect of the PPAR-beta/delta agonist and thus abolished the protective effect. Our results clearly demonstrate that GW0742 treatment reduces the development of inflammation and tissue injury associated with spinal cord trauma.
引用
收藏
页码:465 / 477
页数:13
相关论文
共 50 条
  • [21] Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
    Ferrari, Silvia Martina
    Fallahi, Poupak
    Vita, Roberto
    Antonelli, Alessandro
    Benvenga, Salvatore
    PPAR RESEARCH, 2015, 2015
  • [22] Peroxisome proliferator-activated receptor-γ expression in lung
    Inoue, K
    Kawahito, Y
    Sano, H
    CHEST, 2002, 122 (01) : 386 - 387
  • [23] Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (08) : 943 - 959
  • [24] CIS-DICHLORODIAMMINEPLATINUM UPREGULATES THE EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AND ENHANCES THE CYTOTOXICITY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AGONIST
    Tanaka, Nobuyuki
    Miyajima, Akira
    Hasegawa, Masanori
    Shirotake, Suguru
    Kosaka, Takeo
    Kikuchi, Eiji
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2010, 183 (04): : E379 - E379
  • [25] The expression of peroxisome proliferator-activated receptor-α in rats with alcoholic liver injury
    Long, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 154 - 154
  • [26] Inhibitory role of peroxisome proliferator-activated receptor-β/δ in hepatocarcinogenesis in mice and in vitro
    Shen, Bo
    Li, Ai Min
    Nie, Yu Qiang
    Wan, Yu-Jui Yvonne
    Du, Yan Lei
    Li, Yu Yuan
    Shen, Gui Jia
    HEPATOLOGY, 2014, 60 : 652A - 652A
  • [27] The role of peroxisome proliferator-activated receptor-β/δ in epithelial cell growth and differentiation
    Burdick, AD
    Kim, DJ
    Peraza, MA
    Gonzalez, FJ
    Peters, JM
    CELLULAR SIGNALLING, 2006, 18 (01) : 9 - 20
  • [28] The role of peroxisome proliferator-activated receptor-γ (PPARγ) in Alzheimer's disease
    Jiang, Qingguang
    Heneka, Michael
    Landreth, Gary E.
    CNS DRUGS, 2008, 22 (01) : 1 - 14
  • [29] Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Muscle in the Cerebral Circulation
    De Silva, T. Michael
    Modrick, Mary L.
    Ketsawatsomkron, Pimonrat
    Lynch, Cynthia
    Chu, Yi
    Pelham, Christopher J.
    Sigmund, Curt D.
    Faraci, Frank M.
    HYPERTENSION, 2014, 64 (05) : 1088 - +
  • [30] The peroxisome proliferator-activated receptor-γ agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-α- dependent manner in vitro and in vivo in mice
    Orasanu, Gabriela
    Ziouzenkova, Ouliana
    Devchand, Pallavi R.
    Nehra, Vedika
    Hamdy, Osama
    Horton, Edward S.
    Plutzky, Jorge
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (10) : 869 - 881